|
PCF11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.78489999999032E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62547753035369E-12 |
| Stage1-vs-Stage2 |
3.099000E-01 |
| Stage1-vs-Stage3 |
9.879800E-03 |
| Stage1-vs-Stage4 |
6.302200E-02 |
| Stage2-vs-Stage3 |
5.312300E-02 |
| Stage2-vs-Stage4 |
5.650100E-02 |
| Stage3-vs-Stage4 |
7.956800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.34309946182066E-10 |
| Normal-vs-Asian |
2.57172061424171E-12 |
| Caucasian-vs-AfricanAmerican |
6.441200E-01 |
| Caucasian-vs-Asian |
5.747900E-02 |
| AfricanAmerican-vs-Asian |
4.253400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
6.702400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.21710000000608E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.320000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.015200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.426000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.625400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.806600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.665200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.59179999981963E-07 |
| Classical-VS-Follicular |
8.357700E-02 |
| Classical-VS-Other |
8.632800E-01 |
| Classical-VS-Normal |
1.62481139653892E-12 |
| Tall-VS-Follicular |
1.6636999999875E-06 |
| Tall-VS-Other |
5.964300E-03 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.828600E-01 |
| Follicular-VS-Normal |
2.43950004641391E-09 |
| Other-VS-Normal |
1.588660E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.48587866641992E-12 |
| N0-vs-N1 |
8.110400E-01 |
|
|
